As the International AIDS Conference kicked off in Durban, South Africa, today, two of the nation's most prominent biomedical research institutions announced that they will marry and combine resources to attack the raging coepidemic of tuberculosis and HIV in the region.
18 July 2016 | Science Magazine
The War on Drugs, mass incarceration of drug users, and the failure to provide proven harm reduction and treatment strategies has led to high levels of HIV, tuberculosis, and hepatitis B and C infection among prisoners--far higher than in the general population. With an estimated 30 million people passing in and out of prisons every year, prisoners will be key to controlling HIV and tuberculosis epidemics worldwide, according to a major six-part Series on HIV and related infections in prisoners, published in The Lancet and being presented at the International AIDS Conference in Durban, South Africa.
17 July 2016 | EurekAlert
Urgency in efforts to address the devastating global impact of tuberculosis (TB), and opportunities to make major inroads against the infectious disease, are being featured at TB2016, a two-day conference dedicated exclusively to TB, immediately preceding AIDS 2016 in Durban, South Africa.
16 July 2016 | AIDS 2016
A recent report from UNAIDS said that by 2020, countries should devote 8% of its HIV resources to reducing human rights barriers to accessing services. Currently, less than 1% of Global Fund grant funds is spent on programs to reduce human rights barriers. We have to do more and we have to do it better, says Ralf Jürgens. In this commentary, Ralf describes an intensive effort that the Global Fund is implementing in 15-20 countries, as well as other initiatives the Fund has planned.
11 May 2016 | Global Fund Observer
Sitting in her small flat that she once shared with friends in Zimbabwe's capital Harare, Hope (27), a sex worker chronicles life from her first diagnosis with tuberculosis (TB) and later HIV. A journey, she says, that has never been easy.
24 March 2016 | AVERT
Two years after two new drugs to treat tuberculosis—the first in over 50 years—were conditionally approved for use, only 2% of the 150,000 people who need them have been able to access them, according to Médecins Sans Frontières (MSF).
24 March 2016 | Médecins Sans Frontières
While there has been significant progress in the fight against TB, with 43 million lives saved since 2000, the battle is only half-won: over 4 000 people lose their lives each day to this leading infectious disease. Many of the communities that are most burdened by tuberculosis are those that are poor, vulnerable and marginalized.
24 March 2016 | World Health Organization
When House Appropriations Committee members in 2014 asked then USAID Administrator Raj Shah how the U.S. could combat tuberculosis globally with 19 percent less money, he said not to worry. The Global Fund to Fight AIDS, TB and Malaria, and the President’s Emergency Plan for AIDS Relief would fill the gap, he said.
21 March 2016 | Science Speaks
In what investigators say is a surprise finding, results of a new study appear to strongly affirm the effectiveness of prescribing the anti-tuberculosis drug isoniazid alone — in place of the standard four-drug regimen — to prevent TB and reduce death in people with advanced HIV/AIDS infections. Those with HIV and AIDS are highly susceptible to TB.
21 March 2016 | Johns Hopkins Medicine
The World Health Organization Regional Office for Europe warns that people from the most vulnerable groups in Europe, including migrants and refugees, are at higher risk of multi-drug resistant tuberculosis, said a a spokesperson here on Thursday.
18 March 2016 | Xinhua